SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-18-006425
Filing Date
2018-09-06
Accepted
2018-09-06 07:55:36
Documents
19
Period of Report
2018-09-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_090618.htm 8-K 16587
2 EXHIBIT 10.1 exh_101.htm EX-10.1 52093
3 EXHIBIT 99.1 exh_991.htm EX-99.1 5418
4 GRAPHIC exh101_01.jpg GRAPHIC 330168
5 GRAPHIC exh101_02.jpg GRAPHIC 101297
6 GRAPHIC exh101_03.jpg GRAPHIC 212490
7 GRAPHIC exh101_04.jpg GRAPHIC 214987
8 GRAPHIC exh101_05.jpg GRAPHIC 301182
9 GRAPHIC exh101_06.jpg GRAPHIC 311387
10 GRAPHIC exh101_07.jpg GRAPHIC 336857
11 GRAPHIC exh101_08.jpg GRAPHIC 361858
12 GRAPHIC exh101_09.jpg GRAPHIC 390030
13 GRAPHIC exh101_10.jpg GRAPHIC 393033
14 GRAPHIC exh101_11.jpg GRAPHIC 198775
15 GRAPHIC exh101_12.jpg GRAPHIC 67417
16 GRAPHIC exh101_13.jpg GRAPHIC 423335
17 GRAPHIC exh101_14.jpg GRAPHIC 142492
18 GRAPHIC exh101_15.jpg GRAPHIC 395883
19 GRAPHIC exh101_16.jpg GRAPHIC 155086
  Complete submission text file 0001171843-18-006425.txt   6047109
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-23186 | Film No.: 181056673
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1